PI3K Targeting in Non-solid Cancer.

Kim, Hye Na; Ogana, Heather; Sanchez, Vanessa; Nichols, Cydney; Kim, Yong-Mi

Kim, Hye Na; Ogana, Heather; Sanchez, Vanessa; Nichols, Cydney; Kim, Yong-Mi.

Affiliation

Kim HN; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA.
Ogana H; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA.
Sanchez V; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA.
Nichols C; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA.
Kim YM; Department of Pediatrics, Division of Hematology and Oncology, Children's Hospital Los Angeles, University of Southern California, Los Angeles, California, USA. ymkim@chla.usc.edu.

Curr Top Microbiol Immunol ; 436: 393-407, 2022.

Article de En | MEDLINE | ID: mdl-36243854

Sujet(s)
Mots clés

Acute lymphoblastic leukemia (ALL); Cell adhesion mediated drug resistance (CAM-DR); PI3K/AKT; PI3KÎ³; PI3KÎ´

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Leucémie chronique lymphocytaire à cellules B / Cellules souches mésenchymateuses Limites: Humans Langue: En Journal: Curr Top Microbiol Immunol Année: 2022 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Allemagne

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google